SER Serina Therapeutics, Inc.
$2.22▼ -11.20%
Healthcare
Other
Volume 69.3K
Avg Volume (10D) 73.8K
Key Metrics & Fundamentals
Market Cap
$56.39M
P/E Ratio
–
Div Yield
–%
52W Range
1.22 - 5.83
% vs 50 MA
-5.88%
% vs 200 MA
-1.57%
RSI-14
40.0
MACD Histogram
-0.0500
Beta (1Y vs SPY)
1.37
Free Cash Flow
-$6.71M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$6.19M
COGS
–
Operating Exp
$6.78M
Operating Income
-$6.78M
EBIT
-$6.78M
Pretax Income
-$6.36M
Net Income
-$6.36M
EPS (Diluted)
-0.55
Price & Volume History
Loading chart…
Recent News
Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 10, 2026 8:05 PM
Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2
GlobeNewswire · Sep 9, 2026 11:45 AM
Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire · Aug 13, 2026 8:15 PM
Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire · Jul 24, 2026 10:00 AM
Serina Completes Enrollment, Dosing in First Cohort of Phase 1b Trial in Parkinson's Disease
MT Newswires · Jul 23, 2026 1:06 PM
Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease
GlobeNewswire · Jul 23, 2026 10:00 AM
Serina Therapeutics Appoints Farrell Simon to its Board of Directors
GlobeNewswire · Jul 22, 2026 8:30 PM
Serina Says Panel Clears Dosing More Patients in Phase 1b Trial of SER-252 in Parkinson's Disease
MT Newswires · Jul 9, 2026 4:40 PM
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
GlobeNewswire · Jul 9, 2026 4:10 PM
Gannet BioChem and Serina Therapeutics Enter Development Partnership Supporting SER-252 Program
GlobeNewswire · Jun 30, 2026 1:01 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See SER's money flow as a full page
Social Sentiment
Avg +0.70 · 4 posts
DDDiscussion$YHC - Next Sharplink? - Strategic Ethereum Reserve
r/wallstreetbets · Jul 13, 2025
YHC is presented as a potential 'next' SER company, suggesting positive sentiment.
positive
+0.60
NewsTradeDiscussionSwiss insider just YOLO’d into 20,000 leveraged contracts on his own stock… I’m paying attention
r/wallstreetbets · Apr 11, 2025
The post highlights a potentially concerning insider action, which can be interpreted as a bullish signal. The mention of the transaction details directly related to SER.
positive
+0.80
NewsDiscussionMemeSer Jerome Powell taketh the floor at Hole of Jackson
r/wallstreetbets · Aug 23, 2024
The comments express regret over a stock decline and excitement about its previous performance, indicating a bullish sentiment.
positive
+0.60
DiscussionNewsS-Corp solo 401k part-time employees options?
r/investing · Aug 14, 2024
The post explicitly mentions and explores the option of a SER-IRA, indicating a positive sentiment toward this investment vehicle.
positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.